Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2021-02-16 3:38 pm Sale | 2020-12-31 | 13G | Kodiak Sciences Inc. KOD | Perceptive Advisors LLC | 751,533 1.500% | -2,912,024 (-79.49%) | Filing History |
| 2021-02-16 3:38 pm Unchanged | 2020-12-31 | 13G | Protara Therapeutics, Inc. TARA | Perceptive Advisors LLC | 608,544 5.400% | 0 (Unchanged) | Filing History |
| 2021-02-16 3:37 pm Purchase | 2020-12-31 | 13G | ADMA Biologics, Inc. ADMA | Perceptive Advisors LLC | 16,584,802 17.500% | 500,000 (+3.11%) | Filing History |
| 2021-02-16 3:37 pm Purchase | 2020-12-31 | 13G | Zymeworks Inc. ZYME | Perceptive Advisors LLC | 4,300,999 9.400% | 1,897,973 (+78.98%) | Filing History |
| 2021-02-16 3:36 pm Purchase | 2020-12-31 | 13G | Coherus Oncology, Inc. CHRS | Perceptive Advisors LLC | 4,671,836 6.500% | 1,085,351 (+30.26%) | Filing History |
| 2021-02-16 3:36 pm Purchase | 2020-12-31 | 13G | Albireo Pharma, Inc. ALBO | Perceptive Advisors LLC | 2,360,139 12.400% | 655,809 (+38.48%) | Filing History |
| 2021-02-16 3:36 pm Unchanged | 2020-12-31 | 13G | BridgeBio Pharma, Inc. BBIO | Perceptive Advisors LLC | 6,706,268 5.500% | 0 (Unchanged) | Filing History |
| 2021-02-16 3:35 pm Sale | 2020-12-31 | 13G | Global Blood Therapeutics, Inc. GBT | Perceptive Advisors LLC | 5,674,711 9.200% | -191,015 (-3.26%) | Filing History |
| 2021-02-16 3:35 pm Purchase | 2020-12-31 | 13G | SpringWorks Therapeutics, Inc. SWTX | Perceptive Advisors LLC | 4,177,721 8.600% | 880,199 (+26.69%) | Filing History |
| 2021-02-16 3:35 pm Unchanged | 2020-12-31 | 13G | BCLS Acquisition Corp. BLSA | Perceptive Advisors LLC | 1,000,000 7.000% | 0 (Unchanged) | Filing History |
| 2021-02-16 3:34 pm Purchase | 2020-12-31 | 13G | Athenex, Inc. ATNX | Perceptive Advisors LLC | 676,623 14.500% | 100,000 (+17.34%) | Filing History |
| 2021-02-16 3:33 pm Sale | 2020-12-31 | 13G | Iovance Biotherapeutics, Inc. IOVA | Perceptive Advisors LLC | 9,166,304 6.300% | -245,092 (-2.60%) | Filing History |
| 2021-02-16 3:33 pm Unchanged | 2020-12-31 | 13G | IVERIC bio, Inc. ISEE | Perceptive Advisors LLC | 4,482,713 5.000% | 0 (Unchanged) | Filing History |
| 2021-02-16 3:33 pm Purchase | 2020-12-31 | 13G | Frequency Therapeutics, Inc. FREQ | Perceptive Advisors LLC | 65,193 9.700% | 4,507 (+7.43%) | Filing History |
| 2021-02-16 3:33 pm Purchase | 2020-12-31 | 13G | Provention Bio, Inc. PRVB | Perceptive Advisors LLC | 4,224,389 6.700% | 1,302,815 (+44.59%) | Filing History |
| 2021-02-16 3:33 pm Sale | 2020-12-31 | 13G | Amicus Therapeutics, Inc. FOLD | Perceptive Advisors LLC | 25,112,048 9.700% | -20,316 (-0.08%) | Filing History |
| 2021-02-16 3:31 pm Purchase | 2020-12-31 | 13G | Aldeyra Therapeutics, Inc. ALDX | Perceptive Advisors LLC | 8,703,879 19.100% | 2,418,421 (+38.48%) | Filing History |
| 2021-02-16 3:31 pm Purchase | 2020-12-31 | 13G | RAPT Therapeutics, Inc. RAPT | Perceptive Advisors LLC | 197,185 6.400% | 31,250 (+18.83%) | Filing History |
| 2021-02-16 3:31 pm Sale | 2020-12-31 | 13G | Vapotherm, Inc. VAPO | Perceptive Advisors LLC | 0 0.000% | -225,509 (Position Closed) | Filing History |
| 2021-02-16 3:31 pm Sale | 2020-12-31 | 13G | Zogenix, Inc. ZGNX | Perceptive Advisors LLC | 0 0.000% | -3,709,152 (Position Closed) | Filing History |